Trigeminal Neuralgia: Medical Management Perspective

  • Neil C. Porter


Trigeminal neuralgia is a well-recognized neuropathic pain syndrome characterized by brief paroxysms of facial pain in the distribution of the trigeminal nerve. The syndrome can occur secondary to a number of medical conditions including multiple sclerosis, basilar artery aneurysm, and brain tumor [1]. The disorder can also be idiopathic, the latter instance being known as tic douloureux. Trigeminal neuralgia can strike persons of any age but typically affects older individuals. Treatment options include a number of neuropathic pain medications as well as neurosurgical and radiosurgical interventions. The mainstay of treatment for most individuals, however, remains medication.


Neuropathic Pain Antiepileptic Drug Trigeminal Nerve Trigeminal Neuralgia Complex Regional Pain Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rozen TD. Trigeminal neuralgia and glossopharyngeal neuralgia. Neurol Clin N Am 2004; 22:185–206.Google Scholar
  2. 2.
    Joffroy A, Levivier M, Massager N. Trigeminal neuralgia: pathophysiology and treatment. Acta Neurol Belg 2001; 101:20–25.PubMedGoogle Scholar
  3. 3.
    Rappapor ZH, Devor M. Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion. Pain 1994; 56:127–138.CrossRefGoogle Scholar
  4. 4.
    Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001; 124:2347–2360.CrossRefPubMedGoogle Scholar
  5. 5.
    Kaye AH. Trigeminal neuralgia: vascular compression theory. Clin Neurosurg 2000; 46:499–506.PubMedGoogle Scholar
  6. 6.
    Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsants drug. Lancet 1962; 1:839–840.CrossRefPubMedGoogle Scholar
  7. 7.
    Campbel FG, Graham JG, Zikha KJ. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia. J Neurosurg Neurol Psychiatry 1966; 29:265–267.CrossRefGoogle Scholar
  8. 8.
    Nicol C. A four-year double-blind randomized study of Tegretol in facial pain. Headache 1969; 9:54–57.CrossRefPubMedGoogle Scholar
  9. 9.
    Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966; 15:129–136.PubMedGoogle Scholar
  10. 10.
    Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmcotherapy 2000; 20:152S–158S.CrossRefGoogle Scholar
  11. 11.
    Carrazana E, Mikoshiba I. Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manage 2003; 25:S31–S35.CrossRefPubMedGoogle Scholar
  12. 12.
    Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: reported to cases. Neurology 1997; 48:1467.PubMedGoogle Scholar
  13. 13.
    Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998; 51:611–614.PubMedGoogle Scholar
  14. 14.
    Lunardi G, Leandri M, Albano C, et al. Clinical effectiveness of Lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997; 48:1714–1717.PubMedGoogle Scholar
  15. 15.
    Canavero S, Bonicalzi V. Lamotrigine control of trigeminal neuralgia: an expanded study. J Neurol 1997; 244:527–532.CrossRefPubMedGoogle Scholar
  16. 16.
    Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo-controlled crossover trial. Pain 1997; 73:223–230.CrossRefPubMedGoogle Scholar
  17. 17.
    Zvartau-Hind M, Din MU, Gilani A, et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 2000; 55:1587–1588.PubMedGoogle Scholar
  18. 18.
    Solaro C, Messmer MM, Brichetto G, et al. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage 2001; 21:367–368.CrossRefPubMedGoogle Scholar
  19. 19.
    Bergouignan M. Cures heureuses de nevralgies facials essentielles par diphenyl-hidantoinate de soude. Rev Laryngol Otol Rhinol 1942; 63:34–41.Google Scholar
  20. 20.
    Raskin NH. Facial pain. In: Headache. New York: Churchill Livingstone, 1988:333–374.Google Scholar
  21. 21.
    Zakrzewska JM. Trigeminal neuralgia. In: Medical Management. London: W.B. Saunders, 1955:80–107.Google Scholar
  22. 22.
    Fromm GH, Terrence CF, Chatta AS, Glass JD. Baclofen in trigeminal neuralgia: its effect on the spinal trigeminal nucleus: a pilot study. Arch Neurol 1980; 37(12):768–771.PubMedGoogle Scholar
  23. 23.
    Fromm GH, Terrence CF, Chatta AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Arch Neurol 1984; 15(3):240–244.CrossRefGoogle Scholar
  24. 24.
    Court JE, Kase CS. Treatment of tic douloureaux with a new anticonvulsant (clonazepam). J Neurol Neurosurg Psychiatry 1976; 39:297–299.CrossRefPubMedGoogle Scholar
  25. 25.
    Epstein JB, Marcoe JH. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994; 77:135–140.CrossRefPubMedGoogle Scholar
  26. 26.
    Fusco BM, Alessandri M. Analgesics effect of capsaicin in idiopathic trigeminal neuralgia. Anesth Analg 1992; 74:375–377.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Neil C. Porter
    • 1
  1. 1.Department of NeurologyUniversity of Maryland School of MedicineBaltimoreUSA

Personalised recommendations